Navigation Links
Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
Date:4/6/2011

SAN DIEGO, April 6, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the signing of an exclusive two-year co-promotion agreement to market DIFICID™ (fidaxomicin), in the United States.  DIFICID is a novel antibiotic currently being reviewed for market approval by the FDA for the treatment of Clostridium difficile infection (CDI), which is also known as Clostridium difficile-associated diarrhea (CDAD).  On April 5, 2011, the FDA's Anti-Infective Drugs Advisory Committee voted unanimously that the clinical evidence submitted by Optimer demonstrated the safety and effectiveness of DIFICID for the treatment of CDI, thereby recommending approval of DIFICID as a treatment for CDI. The FDA is expected to complete its review of DIFICID and deliver a decision on market approval by a Prescription Drug User Fee Act (PDUFA) goal date of May 30, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

Under the terms of the agreement, Optimer and Cubist will co-promote DIFICID to physicians, hospitals, long-term care facilities and other healthcare institutions in the United States. Optimer and Cubist will also jointly provide medical affairs support for the product. Optimer plans to strategically build its sales force and medical affairs team.  Optimer's team will be complemented by Cubist's existing U.S. hospital sales force and medical affairs team which is already dedicated to the antibiotic space for CUBICIN® (daptomycin for injection), Cubist's therapy for Staphylococcus aureus bacteremia, including right-sided endocarditis, and complicated skin infections caused by certain Gram-positive b
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
2. Trading Halted Today in Optimer Pharmaceuticals Stock
3. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
4. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
5. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
6. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
7. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
8. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
9. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
10. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 In conjunction ... quarter 2014 financial results press release, you are invited ... broadcast live over the internet on Thursday, August 7, ... Time). A live audio webcast of the ... http://www.durect.com and clicking "Investor Relations."  If you ...
(Date:7/30/2014)... ALEXANDRIA, Va. , July 30, 2014 /PRNewswire-USNewswire/ ... of Managed Care Pharmacy (AMCP) last evening expressed ... developed by the Joint Commission of Pharmacy Practitioners ... other member organizations over a two-year period to ... process for pharmacists.  "Pharmacists are ...
(Date:7/30/2014)... 30, 2014 Research and Markets has announced ... Forecasts to 2019" report to their offering. ... to grow at a lower CAGR in developed countries; however, it ... China , India , and ... The growth of the hematology analyzers and reagents market is ...
Breaking Medicine Technology:DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2Hematology Analyzers & Reagents Market - Forecasts to 2019 2
... PAREXEL International Corporation (Nasdaq: PRXL ... the Company has won the 2010 Scrip Award ... presented to PAREXEL at the sixth annual ... a leading news, data, and information service for the global ...
... 14, 2010 WHAT:You are invited to demo a new ... Panasonic Healthcare Co., Ltd. Currently applying for FDA clearance, ... engine, offering real-time detection of the thickness of the ... is the first comprehensive solution for screening and ...
Cached Medicine Technology:PAREXEL Wins Clinical Research Team of the Year Scrip Award 2PAREXEL Wins Clinical Research Team of the Year Scrip Award 3PAREXEL Wins Clinical Research Team of the Year Scrip Award 4PAREXEL Wins Clinical Research Team of the Year Scrip Award 5Panasonic Unveils CardioHealth® Station - First Comprehensive Screening Solution to Detect Heart Disease in Asymptomatic Population 2
(Date:7/31/2014)... New York, NY (PRWEB) July 31, 2014 ... will host its first-ever event in New York on ... Eventi Hotel in Manhattan. , Featuring keynotes by ... Assemblyman Steve Katz (R-Yorktown), the event will include lunch ... Compassionate Care Act and the work NCIA is doing ...
(Date:7/31/2014)... July 31, 2014 According to a report ... recently underwent partial knee replacement surgery on his left knee. ... two months earlier. The story also reports that Bush was ... hopes to be back on the bike again soon. This ... benefits of partial knee replacement. , “Partial knee replacements ...
(Date:7/31/2014)... ProtonPACS, a division of Radsource, has signed ... Health Association (NRHA), company officials announced today. The partnership ... of rural health providers nationwide. , “We are proud ... Dr. Mark Awh, President of Radsource. “While we are ... are also looking forward to learning from all of ...
(Date:7/31/2014)... 1, 2014) While it is known that members of ... alcohol, a new study finds that female enlistees and ... their civilian counterparts. This study was published today in ... published on behalf of the Inter-University Seminar on Armed ... Lucky Tedrow studied surveys of nearly 9,000 men and ...
(Date:7/31/2014)... Angeles, CA (PRWEB) July 31, 2014 Staying ... can be tricky at best. Men and women get sucked ... husbands, wives, life partners, and taxi services to kids. ... Black, offers her "3 Fast + Fun Ways to Reignite ... free download . , “This is a much better ...
Breaking Medicine News(10 mins):Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Women in military less likely to drink than civilian women 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3
... A new study finds that breast cancer patients who ... effectively, and altering health behaviors live longer than patients ... the December 15, 2008 issue of CANCER, ... study indicates that reducing the stress that can accompany ...
... that DFMO may influence the extent of Barrett,s dysplasia, ... this agent in a larger number of patients is ... and oncology at the Mayo Clinic, Rochester, MN. , ... for Cancer Research,s Seventh Annual International Conference on Frontiers ...
... at The Feinstein Institute for Medical Research have figured out why ... levels that accumulate in the brains of Alzheimer’s patients. , ... ... The Feinstein Institute for Medical Research have figured out why a ...
... known to inhibit the growth of ovarian cancer works in ... die, researchers at The University of Texas M. D. Anderson ... Cancer Research . , The research team also found that ... indicator of a woman,s prospects for surviving ovarian cancer, said ...
... pathway not previously linked to breast cancer is driving ... and disproportionately over-represented in African American women. , The ... represents a class of genes called proteasome targeting complexes. ... tumor suppressor gene p27 by making a new type ...
... effective, say Children,s Hospital of Pittsburgh reseachers , , ... of bone marrow transplantation is the only safe and ... Hospital of Pittsburgh report. , Traditional bone marrow transplants ... in order to destroy a recipient,s bone marrow so ...
Cached Medicine News:Health News:Psychological interventions associated with breast cancer survival 2Health News:DFMO may affect Barrett's esophagus 2Health News:Substance in Red Grapes and Wine Key to Alzheimer's Disease 2Health News:Protein compels ovarian cancer cells to cannibalize themselves 2Health News:UCLA scientists find cell pathway driving a deadly sub-type of breast cancer 2Health News:UCLA scientists find cell pathway driving a deadly sub-type of breast cancer 3Health News:Unique Bone Marrow Transplant Said to Cure Sickle Cell 2
Blunt tipped forceps with small, slightly rounded tips angled perpendicular to the shaft. For grasping peripheral membranes....
... features an advanced design, solid state oscillator ... as many years of clinical experience, has ... for the placement of discrete burns on ... the maximum effect at the target tissue ...
Anterior chamber protein cell meter. Laser flare meter and cell-counting functions are included in this cell meter, with dramatically enhanced measurement of cell volume....
... Rare Earth Intraocular Magnet is especially designed ... foreign bodies. The precise, sleek design of ... observed with electromagnetic devises. Due to its ... the possibility of secondary foreign body incarceration. ...
Medicine Products: